NCT06599684

Study of INV-102 Ophthalmic Solution in Adults With Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy

← 임상시험 허브

레지스트리 요약

진행 상태: 완료 (COMPLETED)
질환/조건: Non-center Involved Diabetic Macular Edema, Non-center Involved Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy, Diabetic Retinopathy, Center-involved Diabetic Macular Edema, Center-involved Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy
시험 유형: 중재 연구 (INTERVENTIONAL)
단계: Phase 2
목적: 치료
중재 유형: 약물
개입·치료: INV-102
Lead Sponsor: Invirsa, Inc. (산업계)

캐시 시각: 2026-10-03 09:00:04

ClinicalTrials.gov에서 보기

요약

Phase 2 study to assess the efficacy of topically administered eyedrops of INV-102 during a 12-week dosing period in subjects with non-center involved DME (NCIDME) associated with NPDR \[Part 1\] and during an 8-week dosing period in subjects with center-involved DME (CIDME) associated with NPDR \[Part 2\].

문의

이 시험 기반 리포트·메디컬라이팅이 필요하시면 문의해 주세요.

리포트 문의 메디컬라이팅 문의 맞춤 리서치 리포트